The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
Specialty Chemicals grew 38% YoY for FY23
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Subscribe To Our Newsletter & Stay Updated
